203 related articles for article (PubMed ID: 24128094)
1. [Co-payment and the hospital pharmacy].
Lamas Díaz MJ; Delgado Sánchez O; Poveda Andrés JL
Farm Hosp; 2013; 37(5):345-7. PubMed ID: 24128094
[No Abstract] [Full Text] [Related]
2. [Radiology and the law. In ambulatory treatment may contrast media be obtained via the hospital pharmacy?].
Frehse M; Kleinke S;
Rofo; 2003 May; 175(5):711-2. PubMed ID: 12816077
[No Abstract] [Full Text] [Related]
3. Can a health care system change?
Lexchin J
CMAJ; 1997 Sep; 157(5):507-8. PubMed ID: 9294383
[No Abstract] [Full Text] [Related]
4. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
5. Controlling spending for prescription drugs.
Altman SH; Parks-Thomas C
N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
[No Abstract] [Full Text] [Related]
6. Health resource allocation. A made-in-Canada description.
Noseworthy T
J Leg Med; 2011 Jan; 32(1):11-26. PubMed ID: 21391053
[No Abstract] [Full Text] [Related]
7. [The importance of biosimilars medicines for private and statutory health insurance].
Bretthauer B
Versicherungsmedizin; 2016 Dec; 68(4):173-5. PubMed ID: 29144116
[TBL] [Abstract][Full Text] [Related]
8. The effect of a patient charge and a prescription regulation on the use of antihypertension drugs in Limburg, The Netherlands.
Starmans B; Janssen R; Schepers M; Verkooijen M
Health Policy; 1994 Jan; 26(3):191-206. PubMed ID: 10133131
[TBL] [Abstract][Full Text] [Related]
9. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
Ha D; Song I; Lee EK; Shin JY
BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
[TBL] [Abstract][Full Text] [Related]
10. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
Harder Yv
Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
[No Abstract] [Full Text] [Related]
11. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
Kirking DM; Ascione FJ; Richards JW
Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
[TBL] [Abstract][Full Text] [Related]
12. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
Gudiksen KL; King JS
J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
[No Abstract] [Full Text] [Related]
13. Prescription drug benefits in a managed care plan: balancing quality and costs.
Heenan J
Med Interface; 1994 Jan; 7(1):84-6, 88, 91-2. PubMed ID: 10131628
[TBL] [Abstract][Full Text] [Related]
14. Pharmac dogma.
Douglas B
N Z Med J; 2007 Feb; 120(1249):U2430. PubMed ID: 17308566
[No Abstract] [Full Text] [Related]
15. Economic evaluation for pharmaceuticals in Germany.
Jönsson B
Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
[No Abstract] [Full Text] [Related]
16. [The rheumatologist's conflict between "off-label" prescription and failure to render assistance].
Hellmich B; Gross WL
Z Rheumatol; 2003 Feb; 62(1):34-5. PubMed ID: 12624800
[No Abstract] [Full Text] [Related]
17. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
18. Coping with Medicare Part D's effects on patient assistance programs.
Askew JP
Am J Health Syst Pharm; 2006 Nov; 63(22):2195-8. PubMed ID: 17090739
[No Abstract] [Full Text] [Related]
19. [Family physicians resist high prescription risk].
Schmidt K
MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
[No Abstract] [Full Text] [Related]
20. Pharmaceuticals in Australia: priorities in a teaching hospital.
Kearney BJ
Physician Exec; 1993; 19(5):63-7. PubMed ID: 10130953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
